^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

TmGPC2 01 CAR-T

i
Other names: TmGPC2 01 CAR-T, GPC2 CAR-T
Associations
Trials
Company:
Gilead, The Children’s Hospital of Philadelphia, University of Pennsylvania
Drug class:
GPC-2-targeted CAR-T immunotherapy
Associations
Trials